SCHEMBL10001250

SCHEMBL10001250

CC(C)(C)c1ccc(-c2nnc(-c3cccc(-n4c5ccc(-c6ccccc6)cc5c5cc(-c6ccccc6)ccc54)c3)o2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ S1PR1 P21453 2/20 0.46
▸ NPC1 O15118 10/20 0.44
▸ RAB9A P51151 10/20 0.44
▸ SMN1; SMN2 Q16637 8/20 0.44
▸ HPGD P15428 4/20 0.44
▸ TSHR P16473 3/20 0.44
▸ KDM4E B2RXH2 5/20 0.43
▸ TP53 P04637 4/20 0.43
▸ POLB P06746 2/20 0.43
▸ EGFR P00533 1/20 0.43
▸ NPSR1 Q6W5P4 1/20 0.41
▸ TDP1 Q9NUW8 1/20 0.41
▸ NFKB1 P19838 2/20 0.41
▸ NFKB2 Q00653 2/20 0.41
▸ RELA Q04206 2/20 0.41
▸ MECP2 P51608 1/20 0.41
▸ ALDH1A1 P00352 3/20 0.40
▸ MAPT P10636 2/20 0.40
▸ GLA P06280 1/20 0.40
▸ ALOX15 P16050 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13230232 0.92 S1PR1 (0.49) S1PR1NPC1RAB9ASMN1; SMN2HPGD
SCHEMBL10820026 0.92 NPC1 (0.47) S1PR1NPC1RAB9ASMN1; SMN2HPGD
SCHEMBL13230234 0.92 S1PR1 (0.49) S1PR1NPC1RAB9ASMN1; SMN2HPGD
SCHEMBL10820025 0.91 S1PR1 (0.48) S1PR1NPC1RAB9ASMN1; SMN2HPGD
SCHEMBL12680716 0.91 S1PR1 (0.45) S1PR1NPC1RAB9ASMN1; SMN2HPGD
SCHEMBL10001253 0.90 S1PR1 (0.45) S1PR1NPC1RAB9ASMN1; SMN2HPGD
SCHEMBL12680744 0.89 S1PR1 (0.47) S1PR1NPC1RAB9ASMN1; SMN2HPGD
SCHEMBL13230198 0.88 S1PR1 (0.46) S1PR1NPC1RAB9ASMN1; SMN2HPGD
SCHEMBL13230183 0.88 S1PR1 (0.46) S1PR1NPC1RAB9ASMN1; SMN2HPGD
SCHEMBL614797 0.87 NPC1 (0.51) S1PR1NPC1RAB9ASMN1; SMN2HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8859113-B2 Carbazole derivatives and organic light-emitting diode device using the same CHINA PETROCHEMICAL DEVELOPMENT CORPORATION (TW) 2014-10-14 — — US disclosed
US-8859113-B2 Carbazole derivatives and organic light-emitting diode device using the same CHINA PETROCHEMICAL DEVELOPMENT CORPORATION (TW) 2014-10-14 — — US disclosed
US-20140175400-A1 Novel Carbazole Derivatives and Organic Light-Emitting Diode Device Using the Same CHINA PETROCHEMICAL DEVELOPMENT CORPORATION (TW) 2014-06-26 — — US disclosed
US-20140175400-A1 Novel Carbazole Derivatives and Organic Light-Emitting Diode Device Using the Same CHINA PETROCHEMICAL DEVELOPMENT CORPORATION (TW) 2014-06-26 — — US disclosed
US-8580396-B2 Carbazole derivatives and organic light-emitting diode device using the same China Petrochemical Development Corp (TW) 2013-11-12 — — US disclosed
US-8580396-B2 Carbazole derivatives and organic light-emitting diode device using the same China Petrochemical Development Corp (TW) 2013-11-12 — — US disclosed
US-20120038264-A1 Novel Carbazole Derivatives and Organic Light-Emitting Diode Device Using the Same CHINA PETROCHEMICAL DEVELOPMENT CORPORATION (TW) 2012-02-16 — — US disclosed
US-20120038264-A1 Novel Carbazole Derivatives and Organic Light-Emitting Diode Device Using the Same CHINA PETROCHEMICAL DEVELOPMENT CORPORATION (TW) 2012-02-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120038264-A1 Novel Carbazole Derivatives and Organic Light-Emitting Diode Device Using the Same DRD1, DRD3, CYBA S1PR1 4757/4885NPC1 510/4885RAB9A 2658/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback